CClinicalTrials.gg
CompletedNCT05005104AAUpdated Aug 13, 2021

Causes of Complicated Appendicitis at Referral Hospital

An observational study in Complicated Appendicitis, sponsored by Haramaya Unversity. Completed at 1 site in Ethiopia. Per ClinicalTrials.gov, last updated 2021-08-13.

Sponsored by Haramaya Unversity · Observational

Study type
Observational
Model
Case-control
Time perspective
Other
Enrollment
402
Sex
All
01

Study summary

The study was conducted on a medical record of previously treated patients for acute appendicitis at HFSUH, Harar, Ethiopia. The study design was case-control with a total sample size of 402.

Read the detailed description

The case-control study conducted at HFSUH was proceeded following the university's protocol and after passing institutional ethical review permission.

02

Conditions studied

  • Complicated Appendicitis

Browse trials for

Keywords

  • complicated appendicitis, acute abdomen
03

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

all patients with a diagnosis of acute appendicitis and admitted to a public hospital in Harari regional state.

Inclusion criteria

  • patients diagnosed with acute appendicitis

Exclusion criteria

Exclusion Criteria:

  • incidental appendectomy patients
04

Study design

Observational model
Case-control
Time perspective
Other
Enrollment
402 participants (actual)
Patient registry
No
05

What researchers measure

Primary outcomes

  1. Number of patients having the predictors of complicated appendicitis.

    Clinical histories like duration of chief complaint, constipation, vomiting, fever, visiting to lower level clinics, presence of comorbidities were used to assess the factors associated with complicated appendicitis.

    Time frame: 1 week

06

Study locations

1 site
  • CHMS
    Harar, Harari NS 251, Ethiopia
07

References and documents

Individual participant data

Plan to share: Undecided — on reasonable request

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT05005104
Lead sponsor
Haramaya Unversity
Responsible party
Badhaasaa (Dr, Haramaya Unversity) — Principal investigator
First posted
Aug 13, 2021
Start date
Feb 1, 2021
Primary completion
Mar 31, 2021
Completion
Jun 28, 2021
Last update
Aug 13, 2021

Study contacts

Badhaasaa Bayissa, MD
principal investigator · HU

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion